- $166.91m
- $14.72m
- 43
- 36
- 40
- 33
Annual income statement for Rezolute, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22.4 | 43.4 | 56 | 70.4 | 79.9 |
| Operating Profit | -22.4 | -43.4 | -56 | -70.4 | -79.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20.9 | -41.1 | -51.8 | -68.5 | -74.4 |
| Net Income After Taxes | -20.9 | -41.1 | -51.8 | -68.5 | -74.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -20.9 | -41.1 | -51.8 | -68.5 | -74.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -20.9 | -41.1 | -51.8 | -68.5 | -74.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.79 | -2.17 | -1.01 | -1.33 | -0.979 |